Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications

Molecular Medicine Today
S Strand, P R Galle

Abstract

T cells can cause the death of tumour cells by two mechanisms, one involving CD95 and the other involving perforin. T-cell activity or reduced tumour-cell responsiveness towards CD95 stimulation might result in an impaired anti-tumour immune response and tumour cell outgrowth. Recent data suggest that de novo expression of the CD95 ligand (CD95L) in tumours might result in elimination of CD95+ anti-tumour lymphocytes, and that tumours might therefore be privileged sites. However, conflicting data on the role of CD95L in transplantation experiments indicate that CD95L expression alone might not be sufficient to confer the status of immune privilege.

References

Jul 2, 1992·Nature·D P Lane
Nov 17, 1995·Science·T S GriffithT A Ferguson
Aug 1, 1994·The Journal of Experimental Medicine·K S HathcockR J Hodes
Jul 20, 1995·Cancer Letters·L B Owen-SchaubD P Bartos
Oct 19, 1995·Nature·D BellgrauR C Duke
Nov 1, 1995·The Journal of Experimental Medicine·P R GalleL Runkel
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J H RussellR Wang
Feb 22, 1996·Nature·H YagitaK Okumura
May 3, 1996·Cell·R Tisch, H McDevitt
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Feb 1, 1996·Current Opinion in Genetics & Development·S Bates, K H Vousden
Jul 1, 1996·Immunological Investigations·L X SunA Uchida
Jan 1, 1997·Immunology Today·P MusianiG Forni
Feb 7, 1997·Cell·S Nagata
Sep 1, 1996·The Journal of Experimental Medicine·J O'ConnellF Shanahan
Mar 15, 1997·The Journal of Clinical Investigation·P SaasP Y Dietrich
Apr 4, 1997·Cell·A V ChervonskyL A Matis
Apr 1, 1997·Molecular Medicine Today·H L Chen, D P Carbone
Sep 5, 2007·Pediatric Radiology·E Jane Karimova, Sue C Kaste

❮ Previous
Next ❯

Citations

May 5, 2001·Pharmacology & Therapeutics·K SharmaY F Shi
Jun 6, 2003·Cancer Treatment Reviews·Joseph M KaminskiBoris Minev
Jul 20, 1999·Dermatologic Clinics·J A Reed, A P Albino
Jul 16, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Kazuya OkadaTakeshi Watanabe
Jul 28, 2005·Journal of Inflammation·Jennifer M RyanBernard P Mahon
Mar 25, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Tohid KazemiMehdi Yousefi
Sep 15, 2009·Biochemical and Biophysical Research Communications·Koji TateishiMasahiro Kurosaka
Oct 27, 2007·Taiwanese Journal of Obstetrics & Gynecology·Chi-Mou JuangMing-Shien Yen
Jun 10, 2003·International Journal of Cancer. Journal International Du Cancer·Shoichiro TsujiMasayuki Imamura
Mar 28, 2006·Biochemical and Biophysical Research Communications·Demelza J NeedhamManfred W Beilharz
Oct 11, 2008·International Journal of Cancer. Journal International Du Cancer·Ana Paula BarreirosSusanne Strand
Jul 31, 2013·Oncoimmunology·Tanja GrimmigAna Maria Waaga-Gasser
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T ShimonishiY Nakanuma
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H HentzeA Wendel
Dec 10, 2003·Oncogene·Jonas A Nilsson, John L Cleveland
Nov 28, 2018·Medical Sciences : Open Access Journal·Gohar HakobyanYuri Tadevosyan
Oct 3, 2002·Nature Reviews. Immunology·Joseph A Trapani, Mark J Smyth
Sep 4, 2004·Blood·Martin Giroux, François Denis
Feb 1, 2003·The Journal of General Virology·Giovanna RappoccioloShirley A Ellis
Nov 15, 2008·Journal of Cellular Biochemistry·S MontagnaroU Pagnini
Jul 28, 2001·European Journal of Gastroenterology & Hepatology·M Schuchmann, P R Galle
Jul 1, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G A WannerW Ertel
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Concetta ConticelloRuggero De Maria
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhanhai SuSusanne Strand
May 19, 2007·Cancer Research·Barbara FingletonLynn M Matrisian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved